EuroPCR 22: ROLEX Study Finds Promising Results in CAD Pts With the Resolute Onyx

Published: 19 May 2022

  • Views:

    Views Icon 377
  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating

Filmed at EuroPCR 2022, Dr Giuseppe Tarantini (University of Padua Medical School, IT) joins us for a short interview on the ROLEX study (NCT03316833). This was a European multi-centre registry, where patients with left main coronary artery disease were treated with a new-generation zotarolimus-eluting stent, the Resolute Onyx. 

Discussion points: 
1. Aim of This Study
2. Resolute Onyx
3. Patient Population and Study Design
4. Main Findings
5. Take-Home Messages
6. Next Steps

Recorded onsite at EuroPCR in Paris, 2022.
Interviewer: Jonathan McKenna

Videographer: Oliver Miles

Editor: Jordan Rance